mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.02 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |